Funding Opportunity PAR-18-346 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this National Insitute of Neurological Disorders and Stroke R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on research experiences, designed to foster the development of physicians as research scientists in areas relevant to the NINDS mission. The research experiences will prepare clinicians to successfully compete for individual NIH mentored career development awards, or where appropriate, independent research awards. This FOA will also support educational activities such that participants of the R25 are expected to attend and participate in an annual workshop specific to this FOA to present their work, discuss progress and plans towards transitioning to the next career stage and to network with other researchers and leaders in their fields. Such success will facilitate their transition from resident/fellow to physician-scientist, and will thus foster retention of a cadre of physician-scientists who will conduct research into the mechanisms of, etiology, and treatment of neurological diseases.

Funding Opportunity PA-18-286 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to encourage submission of Exploratory/Developmental Bioengineering Research Grants (EBRG) applications which establish the feasibility of technologies, techniques or methods that: 1) explore a new multidisciplinary approach to a biomedical challenge; 2) are high-risk but have high impact; and 3) develop data that may lead to significant future research. An EBRG application may propose hypothesis-driven, discovery-driven, developmental, or design-directed research and is appropriate for evaluating unproven approaches for which there is minimal or no preliminary data.

Experience dependent: Hyper Recruitment Solutions (HRS): We are currently looking for a Bioinformatics Developer to join a leading company with offices based in Manchester and Belfast, Northern Ireland. They are a... Manchester

Funding Opportunity RFA-AG-18-023 from the NIH Guide for Grants and Contracts. NeuroHIV is at an inflection point, with an urgent need to understand the mechanisms that cause and modulate the CNS impairment in the era of antiretroviral therapies.

Notice NOT-HD-17-024 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-18-334 from the NIH Guide for Grants and Contracts. The NIDCD is committed to identifying effective interventions for the diagnosis, prevention, or treatment of communication disorders by supporting welldesigned and wellexecuted clinical trials. This funding opportunity announcement (FOA) supports investigator initiated low risk clinical trials addressing the mission and research interests of NIDCD. Clinical trials must meet ALL the following criteria: meet the budget limits of this FOA, not require FDA oversight, are not intended to formally establish efficacy and have low risks to potentially cause physical or psychological harm. It is advisable that only one clinical trial be proposed in each NIDCD Clinical Trials in Communication Disorders R01 application. High risk clinical trials not meeting all the criteria above are referred companion U01 FOA PAR-18-340, NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders.

Funding Opportunity PAR-18-340 from the NIH Guide for Grants and Contracts. The NIDCD is committed to identifying effective interventions for the treatment or prevention of communication disorders by supporting welldesigned and wellexecuted clinical trials. This funding opportunity announcement (FOA) supports a cooperative agreement between an NIDCD Project Scientist and an investigator to support a clinical trial that meets ANY of the following criteria: requires FDA oversight, has annual direct costs equal to or greater than $500,000, that is intended to formally establish efficacy, or has a higher risk to potentially cause physical or psychological harm. These investigator-initiated clinical trials are perceived to benefit from close interaction, oversight, and guidance resulting from a cooperative agreement. Only one clinical trial may be proposed in each NIDCD Clinical Trials in Communication Disorders U01 application. Low risk clinical trials not meeting any of the criteria above are referred to the companion NIDCD Clinical Trials in Communication Disorders (R01-Clinical Trial Required) PA-18-334

This team will be responsible for analysis of cytometry based assays for all phases of clinical studies and trials at BMS....
From Bristol-Myers Squibb - Sun, 12 Nov 2017 09:00:42 GMT - View all Pennington, NJ jobs

Communicate effectively with central labs, external vendors and BMS labs engaged in sample analysis to ensure consistent execution of biomarker processing,...
From Bristol-Myers Squibb - Sat, 11 Nov 2017 14:04:25 GMT - View all Princeton, NJ jobs

Please include a cover letter stating research interests and experiences, curriculum vitae, and names and contact information of three references....
From City Of Hope - Sat, 11 Nov 2017 00:57:30 GMT - View all United States jobs

Experience with statistical tools for experimental analysis, standard bioinformatics tools, and programing languages such as Matlab, Python, R etc. is desirable...
From GenapSys - Sat, 11 Nov 2017 00:19:27 GMT - View all United States jobs

Key responsibilities include experimental design, analysis and integration of complex and diverse data, interpretation of findings, scientific writing and...
From Carolinas HealthCare System - Fri, 10 Nov 2017 20:53:10 GMT - View all Charlotte, NC jobs

Negotiable: Paramount Recruitment: Statistical Geneticist/ Analyst London Paramount are working in partnership with Genomics England to expand their team in order to deliver success Paramount are working in partnership with Genomics England to expand their team in order to with the 100,00 London, England

Ability to convey information clearly and provide analysis as needed. Use cases include media asset management, big data, bioinformatics, IoT, and backup...
From Cloudian - Fri, 10 Nov 2017 07:30:16 GMT - View all United States jobs

Funding Opportunity RFA-HD-18-035 from the NIH Guide for Grants and Contracts. The primary purpose of this announcement is to support and facilitate multidisciplinary approaches to the development of new and/or improved contraceptive methods for both men and women through the formation of Contraceptive Research Centers. This FOA also allows the inclusion of behavioral and social science research projects to inform on contraceptive use and non-use of marketed products or products in clinical development. The Centers will serve as a national resource for development of early stage investigators electing to pursue careers in contraceptive research.

Funding Opportunity RFA-DK-17-038 from the NIH Guide for Grants and Contracts. The goal of this FOA is to support innovative, basic and translational research in two areas, gastrointestinal (GI) mucosal immunology and liver disease. The emphasis for GI mucosal immunology is on elucidation of mechanisms whereby innate and adaptive immunity in the GI tract interacts with HIV infection in the presence or absence of antiretroviral therapy (ART) and contributes to HIV infection, persistence, disruption of GI homeostasis, and pathogenesis. The emphasis for liver disease is on pathophysiologic mechanisms of injury to the liver and the biliary system during HIV infection and epidemiological studies of liver diseases and disorders in HIV patients.

Funding Opportunity RFA-HL-18-027 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of of highly trained investigators from diverse backgrounds underrepresented in research. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations. This FOA invites applications from Institutions with eligible faculty members to undertake special study and supervised research under a mentor who is an accomplished investigator in the research area proposed and has experience in developing independent investigators.

Notice NOT-AA-17-014 from the NIH Guide for Grants and Contracts

Notice NOT-AA-17-013 from the NIH Guide for Grants and Contracts

Notice NOT-TR-18-006 from the NIH Guide for Grants and Contracts